Onychomycosis-Tinea-Unguium-Drug-Sales-Market-Report-2017
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
3.3 USA <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and <strong>Market</strong> Share (%) by Type<br />
25<br />
3.4 USA <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and <strong>Market</strong> Share (%) by<br />
Applications 26<br />
4 China <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> (<strong>Sales</strong>, Revenue and Price) 28<br />
4.1 China <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Sales</strong> and Revenue (2012-<strong>2017</strong>) 28<br />
4.2 China <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and <strong>Market</strong> Share (%) by<br />
Players 28<br />
4.3 China <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and <strong>Market</strong> Share (%) by Type<br />
30<br />
4.4 China <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and <strong>Market</strong> Share (%) by 32<br />
5 Europe <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> (<strong>Sales</strong>, Revenue and Price) 34<br />
5.1 Europe <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and Value (2012-<strong>2017</strong>) 34<br />
5.2 Europe <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and <strong>Market</strong> Share (%) by<br />
Players 35<br />
5.3 Europe <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and <strong>Market</strong> Share (%) by<br />
Type 37<br />
5.4 Europe <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and <strong>Market</strong> Share (%) by<br />
Applications 38<br />
6 Japan <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> (<strong>Sales</strong>, Revenue and Price) 41<br />
6.1 Japan <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and Value (2012-<strong>2017</strong>) 41<br />
6.2 Japan <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and <strong>Market</strong> Share (%) by<br />
Players 41<br />
6.3 Japan <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue (M USD)and <strong>Market</strong> Share (%) by Type<br />
43<br />
6.4 Japan <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Sales</strong> and <strong>Market</strong> Share (%) by Applications 45<br />
7 Analysis of <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Industry Key Manufacturers 47<br />
7.1 Johnson & Johnson 47<br />
7.1.1 Company Profile 47<br />
7.1.2 Product Information 48
Change language